| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |